This topic contains a solution. Click here to go to the answer

Author Question: A variable that precedes an outcome of interest and increases the chances that the negative outcome ... (Read 114 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
A variable that precedes an outcome of interest and increases the chances that the negative outcome will occur is a(n) ____.
 
  a. risk factor
 b. protective factor
 c. predictive factor
 d. epidemiological factor

Question 2

Variables that are associated at a particular point in time with no clear proof that one precedes the other are said to be ____.
 
  a. predictive
 b. moderating
  c. correlated
 d. comorbid



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagn

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

a

Answer to Question 2

c




rmenurse

  • Member
  • Posts: 513
Reply 2 on: Jun 22, 2018
Gracias!


Sarahjh

  • Member
  • Posts: 370
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library